We are live on
!
Find out more
CS
Credit Suisse Portfolio holdings
AUM
$104B
1-Year Est. Return
34.76%
This Fund
S&P 500
This Quarter
Est. Return
+8.83%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+398.7%
AUM
$188B
AUM Growth
+$6.54B
(+3.6%)
Cap. Flow
-$6.74B
Cap. Flow
% of AUM
-3.58%
Top 10 Holdings %
Top 10 Hldgs %
16.94%
Holding
4,804
New
438
Increased
1,801
Reduced
1,889
Closed
333
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$387M |
| 2 |
iShares China Large-Cap ETF
FXI
|
+$183M |
| 3 |
iShares MSCI Brazil ETF
EWZ
|
+$144M |
| 4 |
Zai Lab
ZLAB
|
+$123M |
| 5 |
Halliburton
HAL
|
+$115M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$832M |
| 2 |
Alibaba
BABA
|
+$374M |
| 3 |
Microsoft
MSFT
|
+$321M |
| 4 |
Apple
AAPL
|
+$273M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$262M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.74% |
| 2 | Healthcare | 10.34% |
| 3 | Financials | 8.3% |
| 4 | Consumer Discretionary | 7.2% |
| 5 | Communication Services | 5.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3451
Conduent
CNDT
$267M
| $714K | ﹤0.01% |
133,742
-13,718
| -9% | -$81.9K |
|
|
RETA
3452
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $711K | ﹤0.01% |
26,960
-765
| -3% | -$59.2K |
|
|
CIO
3453
DELISTED
City Office REIT
CIO
| $710K | ﹤0.01% |
36,022
+3,057
| +9% | +$56.2K |
|
3454
Corsair Gaming
CRSR
$1.22B
| $710K | ﹤0.01% |
33,801
+2,844
| +9% | +$68K |
|
3455
LeMaitre Vascular
LMAT
$1.81B
| $709K | ﹤0.01% |
14,094
-696
| -5% | -$36K |
|
|
TARO
3456
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $709K | ﹤0.01% |
14,157
-835
| -6% | -$46.8K |
|
|
CCRN
3457
DELISTED
Cross Country Healthcare
CCRN
| $707K | ﹤0.01% |
+25,463
| New | +$617K |
|
3458
Ocugen
OCGN
$434M
| $707K | ﹤0.01% |
155,256
+26,138
| +20% | +$197K |
|
3459
CALL
Shake Shack
SHAK
$3B
| $707K | ﹤0.01% |
9,800
+8,000
| +444% | +$608K |
|
3460
CALL
O'Reilly Automotive
ORLY
$76.3B
| $706K | ﹤0.01% |
+15,000
| New | +$649K |
|
3461
CALL
Global X Silver Miners ETF NEW
SIL
$4.5B
| $704K | ﹤0.01% |
+19,200
| New | +$728K |
|
3462
Ituran Location and Control
ITRN
$1.1B
| $703K | ﹤0.01% |
26,327
-1,811
| -6% | -$47.5K |
|
3463
IDT Corp
IDT
$1.64B
| $700K | ﹤0.01% |
+15,844
| New | +$805K |
|
3464
Hess Midstream
HESM
$5.15B
| $698K | ﹤0.01% |
+25,239
| New | +$654K |
|
3465
KraneShares Global Carbon Strategy ETF
KRBN
$141M
| $698K | ﹤0.01% |
+13,711
| New | +$619K |
|
|
LICY
3466
DELISTED
Li-Cycle Holdings Corp.
LICY
| $697K | ﹤0.01% |
8,750
| – | – |
|
|
VIVO
3467
DELISTED
Meridian Bioscience Inc
VIVO
| $697K | ﹤0.01% |
34,157
+2,285
| +7% | +$43.8K |
|
3468
American Vanguard Corp
AVD
$73.2M
| $696K | ﹤0.01% |
42,504
+22,186
| +109% | +$348K |
|
3469
Clover Health Investments
CLOV
$2.18B
| $695K | ﹤0.01% |
186,567
+98,922
| +113% | +$607K |
|
3470
Kura Oncology
KURA
$817M
| $692K | ﹤0.01% |
49,383
+5,938
| +14% | +$96.2K |
|
3471
Seres Therapeutics
MCRB
$49.8M
| $692K | ﹤0.01% |
4,153
+1,830
| +79% | +$291K |
|
3472
Caleres
CAL
$481M
| $691K | ﹤0.01% |
30,470
-765
| -2% | -$18.3K |
|
|
MODN
3473
DELISTED
MODEL N, INC.
MODN
| $691K | ﹤0.01% |
23,032
-14
| -0.1% | -$438 |
|
3474
Quanex
NX
$959M
| $689K | ﹤0.01% |
27,805
+2,359
| +9% | +$52.6K |
|
|
IDEX
3475
DELISTED
Ideanomics, Inc. Common Stock
IDEX
| $689K | ﹤0.01% |
4,595
+2,352
| +105% | +$502K |
|
Similar funds
CSIA
CAN
VAM
CA
MNG
DPAM
ICG
CW
Credit Suisse's Q4 2021 Portfolio in Review
As of Q4 2021, Credit Suisse held 4,804 positions worth $188B, up 3.6% from $182B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Credit Suisse withdrew a net $6.74B in Q4 2021, closing 333 positions and reducing 1,889 holdings. Its most notable exit was Kansas City Southern, an estimated $126M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Credit Suisse opened a new position in Bank of America Series L worth $48.1M.
- Credit Suisse's largest Q4 2021 buy was Bank of America Series L: 33,252 shares worth $48.1M.
- Credit Suisse added most to Linde in Q4 2021, an estimated $387M increase.
- Credit Suisse's biggest Q4 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $832M.
- Credit Suisse fully exited Kansas City Southern in Q4 2021, selling an estimated $126M.
- Credit Suisse's ten largest holdings make up 17% of its $188B portfolio in Q4 2021.
- Credit Suisse opened 438 new positions and closed 333 in Q4 2021.
- Credit Suisse's portfolio value rose 3.6% quarter-over-quarter to $188B.
Based on Credit Suisse's 13F filing for Q4 2021, filed 14 Feb 2022.